BG107793A - Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' - Google Patents

Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' Download PDF

Info

Publication number
BG107793A
BG107793A BG107793A BG10779303A BG107793A BG 107793 A BG107793 A BG 107793A BG 107793 A BG107793 A BG 107793A BG 10779303 A BG10779303 A BG 10779303A BG 107793 A BG107793 A BG 107793A
Authority
BG
Bulgaria
Prior art keywords
propyl
piperidine
methoxyquinolin
carboxylic acid
hydroxy
Prior art date
Application number
BG107793A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eric Bacque
Jean-Christophe Carry
Youssef El-Ahmad
Michel Evers
Philippe Hubert
Jean-Luc Malleron
Serge Mignani
Guy Pantel
Michel Tabart
Fabrice Viviani
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG107793A publication Critical patent/BG107793A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG107793A 2000-11-15 2003-05-09 Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа' BG107793A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2001/003559 WO2002040474A2 (fr) 2000-11-15 2001-11-14 Derives heterocyclylalcoyl piperidine et leur application comme antimicrobiens

Publications (1)

Publication Number Publication Date
BG107793A true BG107793A (bg) 2004-08-31

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107793A BG107793A (bg) 2000-11-15 2003-05-09 Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа'

Country Status (28)

Country Link
EP (2) EP1337529B1 (sk)
JP (1) JP2004514661A (sk)
KR (1) KR100849608B1 (sk)
CN (1) CN1483031A (sk)
AR (1) AR034006A1 (sk)
AT (1) ATE337311T1 (sk)
AU (2) AU1836502A (sk)
BG (1) BG107793A (sk)
BR (1) BR0115312A (sk)
CA (1) CA2429311A1 (sk)
CZ (1) CZ20031316A3 (sk)
DE (1) DE60122567T2 (sk)
DK (1) DK1337529T3 (sk)
EA (1) EA200300568A1 (sk)
EE (1) EE200300207A (sk)
ES (1) ES2271119T3 (sk)
FR (1) FR2816618B1 (sk)
HR (1) HRP20030379A2 (sk)
HU (1) HUP0303758A3 (sk)
IL (1) IL155841A0 (sk)
NO (2) NO20032187L (sk)
PL (1) PL363004A1 (sk)
PT (1) PT1337529E (sk)
SK (1) SK5822003A3 (sk)
TN (1) TNSN01160A1 (sk)
WO (1) WO2002040474A2 (sk)
YU (1) YU46803A (sk)
ZA (1) ZA200303794B (sk)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
ES2340484T3 (es) 2002-11-05 2010-06-04 Glaxo Group Limited Agentes antibacterianos.
EP1567520B1 (en) 2002-12-04 2008-10-15 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
US7605169B2 (en) 2005-01-25 2009-10-20 Glaxo Group Limited Antibacterial agents
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
CN101166730A (zh) 2005-03-01 2008-04-23 惠氏公司 噌啉化合物及其作为肝x受体调节剂的用途
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ES2376488T3 (es) 2006-01-26 2012-03-14 Actelion Pharmaceuticals Ltd. Antibióticos de tetrahidropirano.
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
AR067008A1 (es) 2007-06-15 2009-09-30 Actelion Pharmaceuticals Ltd Derivados 3- amino-6-(1- amino - etil)-tetrahidropirano
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
CN107163038B (zh) * 2012-08-15 2020-07-28 葛兰素集团有限公司 化学方法
SG11201700566SA (en) 2014-08-22 2017-03-30 Glaxosmithkline Ip Dev Ltd Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20072142L (no) 2007-04-25
AU2002218365B2 (en) 2007-07-05
TNSN01160A1 (fr) 2005-11-10
EP1337529B1 (fr) 2006-08-23
IL155841A0 (en) 2003-12-23
SK5822003A3 (en) 2004-06-08
CZ20031316A3 (cs) 2003-10-15
EP1337529A2 (fr) 2003-08-27
ATE337311T1 (de) 2006-09-15
FR2816618B1 (fr) 2002-12-27
DK1337529T3 (da) 2006-12-18
FR2816618A1 (fr) 2002-05-17
ZA200303794B (en) 2004-06-29
EA200300568A1 (ru) 2003-12-25
JP2004514661A (ja) 2004-05-20
CA2429311A1 (en) 2002-05-23
KR100849608B1 (ko) 2008-07-31
ES2271119T3 (es) 2007-04-16
WO2002040474A3 (fr) 2002-10-31
AU1836502A (en) 2002-05-27
HRP20030379A2 (en) 2005-04-30
BR0115312A (pt) 2003-09-23
NO20032187L (no) 2003-06-26
EE200300207A (et) 2003-08-15
PL363004A1 (en) 2004-11-15
DE60122567D1 (de) 2006-10-05
AR034006A1 (es) 2004-01-21
EP1695964A1 (fr) 2006-08-30
PT1337529E (pt) 2006-12-29
WO2002040474A2 (fr) 2002-05-23
HUP0303758A3 (en) 2009-08-28
HUP0303758A2 (hu) 2004-03-01
KR20030060934A (ko) 2003-07-16
CN1483031A (zh) 2004-03-17
NO20032187D0 (no) 2003-05-14
YU46803A (sh) 2006-05-25
DE60122567T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
BG107793A (bg) Х...'...ро-иклилалкилпип...ридинови производни, 'яхно'о пол"-аван... и 'ъ''ави, кои'о ги 'ъдържа'
US6603005B2 (en) Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
US6602884B2 (en) Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
US6403610B1 (en) Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US7232834B2 (en) Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
JP4262481B2 (ja) キノリルプロピルピペリジン誘導体、その製造およびそれを含む組成物
AU2003278297A1 (en) Quinolylpropylpiperidine derivatives and use thereof as antimicrobial agents
ZA200202073B (en) Quinolyl propyl piperidine derivatives and their use as antibacterial agents.
CN101023076A (zh) 4－取代的喹啉衍生物，其制备的方法和中间体，以及含有它们的药物组合物
KR20120011093A (ko) 치환된 헤테로사이클릭 유도체 및 조성물 및 항균제로서의 이의 약학적 용도
AU658905B2 (en) Methanoanthracenes having antidopaminergic activity
CA2520764A1 (en) 4-substituted quinolein derivatives with antimicrobial activity
US7232833B2 (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
CZ20004587A3 (en) Tetrahydroquinoline derivatives
US6806277B2 (en) Quinolylpropylpiperidine derivatives, preparation process and intermediates, and compositions including them